Your browser is no longer supported. Please, upgrade your browser.
BCR CR Bard Inc. monthly Stock Chart
BCR [NYSE]
CR Bard Inc.
IndexS&P 500 P/E103.79 EPS (ttm)1.77 Insider Own0.50% Shs Outstand73.89M Perf Week0.43%
Market Cap13.57B Forward P/E16.67 EPS next Y11.02 Insider Trans-39.51% Shs Float73.57M Perf Month4.46%
Income133.50M PEG10.59 EPS next Q2.18 Inst Own91.30% Short Float1.49% Perf Quarter0.00%
Sales3.42B P/S3.97 EPS this Y-52.90% Inst Trans1.16% Short Ratio2.04 Perf Half Y-7.46%
Book/sh20.00 P/B9.18 EPS next Y10.58% ROA5.40% Target Price202.14 Perf Year5.59%
Cash/sh13.56 P/C13.55 EPS next 5Y9.80% ROE16.30% 52W Range162.96 - 201.94 Perf YTD-2.90%
Dividend0.96 P/FCF- EPS past 5Y-19.80% ROI5.50% 52W High-9.03% Beta0.65
Dividend %0.52% Quick Ratio1.30 Sales past 5Y4.70% Gross Margin62.00% 52W Low12.73% ATR4.90
Employees13900 Current Ratio1.60 Sales Q/Q0.40% Oper. Margin17.50% RSI (14)50.84 Volatility2.62% 2.61%
OptionableYes Debt/Eq0.95 EPS Q/Q4.10% Profit Margin8.00% Rel Volume1.02 Prev Close181.50
ShortableYes LT Debt/Eq0.78 EarningsJan 28 AMC Payout25.00% Avg Volume538.16K Price183.70
Recom2.60 SMA200.84% SMA50-0.39% SMA2000.31% Volume548,164 Change1.21%
Nov-12-15Initiated Citigroup Buy
Aug-27-15Upgrade Goldman Neutral → Buy
Apr-24-15Reiterated Barclays Equal Weight $175 → $185
Jan-30-15Reiterated Barclays Equal Weight $150 → $175
Jun-18-14Downgrade Barclays Overweight → Equal Weight $155 → $150
Mar-06-14Reiterated Barclays Overweight $150 → $160
Jan-09-14Reiterated Barclays Overweight $140 → $150
Oct-23-13Reiterated Barclays Overweight $135 → $140
Sep-04-13Initiated Needham Hold
Jul-24-13Reiterated Barclays Overweight $112 → $125
Jun-04-13Reiterated Deutsche Bank Hold $98 → $106
Mar-08-13Reiterated Northland Capital Market Perform $105 → $111
Feb-01-13Reiterated Barclays Overweight $117 → $112
Feb-01-13Initiated Mizuho Neutral $88 → $94
Jan-04-13Reiterated Deutsche Bank Hold $93 → $97
Nov-20-12Initiated Stifel Nicolaus Hold
Oct-24-12Reiterated Mizuho Neutral $93 → $88
Sep-24-12Upgrade Barclays Underweight → Overweight $101 → $117
Apr-25-12Reiterated Mizuho Neutral $86 → $93
Feb-23-12Initiated Northland Securities Market Perform $105
Feb-12-16 01:29PM  BARD C R INC /NJ/ Files SEC form 10-K, Annual Report
08:07AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bearish Manner : February 12, 2016
Feb-02-16 05:17PM  C.R. Bard, Inc. (New Jersey) Value Analysis (NYSE:BCR) : February 2, 2016
10:18AM  C.R. Bard, Inc. (New Jersey) Earnings Analysis: Q4, 2015 By the Numbers
08:03AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : February 2, 2016
Jan-29-16 11:35AM  5 Stocks You Need to Sell Now at TheStreet
11:19AM  C.R. Bard Does Not Look Very Healthy
09:25AM  C.R. Bard (BCR) Beats Q4 Earnings, FY16 View Positive
03:43AM  Edited Transcript of BCR earnings conference call or presentation 28-Jan-16 10:00pm GMT
Jan-28-16 04:39PM  C.R. Bard tops Street 4Q forecasts
04:25PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:15PM  Bard Announces Fourth Quarter Results Business Wire
07:07AM  Q4 2015 C R Bard Inc Earnings Release - After Market Close
Jan-25-16 11:20AM  Can C.R. Bard (BCR) Pull an Earnings Surprise in Q4?
Jan-21-16 05:25PM  BARD C R INC /NJ/ Files SEC form 8-K, Other Events
Jan-05-16 11:00AM  Bard to Present at J. P. Morgan Healthcare Conference Business Wire
08:10AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bearish Manner : January 5, 2016
Jan-04-16 12:00PM  Bard to Host Earnings Conference Call on January 28, 2016 Business Wire
Dec-29-15 07:33AM  Meet This Year's Best Consumer Discretionary ETF
Dec-28-15 02:06PM  Celgene Soared after Settling Patent Litigation
Dec-18-15 09:11AM  CR Bard Is Heading for a Spill
Dec-09-15 04:30PM  Bard Declares Quarterly Dividend Business Wire
Dec-08-15 01:16PM  BARD C R INC /NJ/ Financials
Dec-02-15 02:17PM  C.R. Bard, Inc. (New Jersey) Value Analysis (NYSE:BCR) : December 2, 2015
08:53AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : December 2, 2015
Dec-01-15 08:23AM  What Do Hedge Funds Think of C.R. Bard, Inc. (BCR)? at Insider Monkey
Nov-30-15 12:01PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Liberator Medical Holdings, Inc. of Commencement of a Class Action Challenging the Fairness of the Sale of the Company to C. R. Bard, Inc. -- LBMH GlobeNewswire
Nov-29-15 12:36PM  Medivation Inc (MDVN): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-24-15 04:37PM  BARD C R INC /NJ/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance
10:00AM  Bard to Present at the Piper Jaffray Healthcare Conference Business Wire
Nov-23-15 12:24PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Liberator Medical Holdings, Inc. of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to C. R. Bard, Inc. -- LBMH PR Newswire
11:20AM  C.R. Bard to Acquire Liberator Medical for $181M; Stock Gains
Nov-21-15 05:09PM  LIBERATOR MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Liberator Medical Holdings, Inc. PR Newswire
Nov-20-15 11:19AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Liberator Medical Holdings, Inc. of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to C. R. Bard, Inc. -- LBMH Accesswire
10:06AM  Wolf Popper LLP Investigates Claims That the Proposed Acquisition of Liberator Medical Holdings, Inc. May Not Be In the Best Interests of Its Investors PR Newswire
07:27AM  Bard Agrees to Acquire Liberator Medical Business Wire
07:24AM  Liberator Medical Holdings to Be Acquired by C. R. Bard for Approximately $181 Million Marketwired
Nov-16-15 01:09PM  Dividend Aristocrats Part 25 of 52: C R Bard Inc (BCR) at Insider Monkey
Nov-13-15 11:00AM  Hologic Tops Large-Cap Stocks in Year-to-Date Performance
Nov-10-15 01:30PM  Bard to Present at the Stifel Healthcare Conference Business Wire
01:21PM  C.R. Bard, Inc. (New Jersey) Earnings Q3, 2015
Oct-23-15 03:03PM  BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report
10:20AM  C.R. Bard (BCR) Beats on Q3 Earnings & Sales, Guides Up
12:30AM  Edited Transcript of BCR earnings conference call or presentation 22-Oct-15 9:00pm GMT
Oct-22-15 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today
04:42PM  C.R. Bard reports 3Q loss
04:24PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:15PM  Bard Announces Third Quarter Results Business Wire
07:07AM  Q3 2015 C R Bard Inc Earnings Release - After Market Close
Oct-20-15 11:42AM  Lawsuit Details How Law Firms Borrow And Pay Millions To Get Mass Tort Cases at Forbes
Oct-16-15 02:05PM  C.R. Bard (BCR) Set to Outshine Earnings Estimates in Q3
10:02AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : October 16, 2015
Oct-14-15 04:31PM  BARD C R INC /NJ/ Files SEC form 8-K, Change in Directors or Principal Officers
04:15PM  Bard Declares Quarterly Dividend Business Wire
Oct-12-15 07:30PM  Lutonix® Global Real-World Registry Outcomes Presented at TCT 2015 Business Wire
Oct-07-15 02:07PM  How are XLVs Moving Averages Trending?
Oct-05-15 04:31PM  BARD C R INC /NJ/ Files SEC form 8-K, Other Events
01:00PM  C.R. Bard (BCR): Here's a Stock That Could Climb 15% at TheStreet
Oct-02-15 12:50PM  C.R. Bard Gains Full Ownership of Medicon, Expands in Japan
Oct-01-15 11:30AM  Bard to Host Earnings Conference Call on October 22, 2015 Business Wire
10:54AM  10 Best Health Care Stocks in the Third Quarter at TheStreet
Sep-30-15 09:59AM  C.R. Bard to Acquire Full Japanese Venture at The Wall Street Journal
08:40AM  Bard Agrees to Acquire Full Ownership of its Joint Venture in Japan Business Wire
Sep-29-15 02:33PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : September 29, 2015
10:46AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bearish Manner : September 29, 2015
Sep-28-15 01:25PM  LabCorp Well Poised on Covance Buyout, Strategic Alliances
Sep-25-15 09:32AM  Strength Seen in Steris (STE): Stock Moves 8% Higher
Sep-11-15 01:27PM  The Biotech Sector Is in a Downward Long-Term Trend
Sep-10-15 12:00PM  Bard to Present at Morgan Stanley Global Healthcare Conference Business Wire
Aug-31-15 02:25PM  Henry Schein Poised on Acquisitions, Strong Fundamentals
Aug-28-15 11:03AM  C.R. Bard, Inc. (New Jersey) Earnings Q2, 2015
Aug-27-15 08:40AM  Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff
06:16AM  C.R. Bard upgraded by Goldman
Aug-04-15 03:04PM  Bard Said to Pay $200 Million to Settle Vaginal Mesh Cases at Bloomberg
Aug-03-15 07:00AM  CMS Approves Add-on Payment for Lutonix® Drug-Coated Balloon for Inpatient Use Business Wire
Jul-29-15 09:03AM  Thermo Fisher Scientific, Inc. Earnings Analysis: By the Numbers
Jul-28-15 07:04AM  Edited Transcript of BCR earnings conference call or presentation 23-Jul-15 9:00pm GMT
Jul-24-15 01:15PM  BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report
10:35AM  C.R. Bard (BCR) Beats Q2 Earnings & Revenues, Guides Up - Analyst Blog
06:20AM  Bard (C.R.) (BCR) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
Jul-23-15 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today
04:20PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:18PM  C.R. Bard reports 2Q loss
04:05PM  Bard Announces Second Quarter Results Business Wire
07:07AM  Q2 2015 C R Bard Inc Earnings Release - After Market Close
Jul-21-15 12:37PM  BARD C R INC /NJ/ Files SEC form 8-K, Other Events
Jul-20-15 04:30PM  Can C.R. Bard (BCR) Surprise Earnings Estimates in Q2? - Analyst Blog
Jul-12-15 03:59PM  Steady Eddy and his stalwart blog
Jul-01-15 12:00PM  Bard to Host Earnings Conference Call on July 23, 2015 Business Wire
Jun-26-15 02:40PM  CR Bard's Lutonix DCB Proves Effective in LEVANT 2 Study - Analyst Blog
Jun-25-15 07:30AM  The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA Business Wire
Jun-24-15 02:10PM  Covidien agrees to settle some cases over transvaginal mesh devices
02:10PM  Henry Schein's Buyout Plan Eyes Nordic Animal Health Market - Analyst Blog
Jun-18-15 01:37PM  BARD C R INC /NJ/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jun-16-15 02:13PM  Edited Transcript of BCR presentation 12-May-15 11:20pm GMT
Jun-10-15 04:06PM  Bard Announces $500 Million Share Repurchase Authorization Business Wire
04:05PM  Bard Increases Quarterly Dividend Business Wire
02:10PM  C. R. Bard's Lutonix DCB Gets Full Reimbursement Approval - Analyst Blog
Jun-09-15 11:50AM  CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use Business Wire
May-27-15 12:57PM  Top trades for the 2nd half: COST, LPL, SCHW & NVDA
C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products that include specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as other products, such as irrigation, wound drainage, and original equipment manufacturers' products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Groetelaars John PGroup PresidentFeb 10Sale187.163,319621,18318,841Feb 12 02:08 PM
WEILAND JOHN HPresident and COOFeb 09Sale181.108,8981,611,44653,078Feb 10 05:45 PM
Collins Timothy PGroup PresidentFeb 09Sale181.244,205762,09625,076Feb 10 05:45 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 09Sale180.623,407615,35818,710Feb 10 05:45 PM
RING TIMOTHY MChairman and CEOFeb 09Sale181.204,836876,29493,896Feb 10 05:45 PM
Naughton Gail KDirectorFeb 02Sale187.88584109,7251,511Feb 03 10:26 AM
Thompson Tommy GDirectorFeb 02Sale188.752,319437,7176,536Feb 03 10:26 AM
BARD C R INC /NJ/10% OwnerJan 21Buy0.011,000100Jan 21 05:24 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 16Option Exercise97.694,662455,40728,308Dec 17 05:27 PM
Christian Patricia GVP -Quality, Reg & Med AffairsDec 16Sale190.001,908362,5209,413Dec 17 05:27 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 16Sale190.004,662885,78023,646Dec 17 05:27 PM
WEILAND JOHN HPresident and COODec 16Sale190.306,0961,160,09367,409Dec 17 05:27 PM
WEILAND JOHN HPresident and COODec 15Option Exercise84.5813,5901,149,37487,095Dec 17 05:27 PM
WEILAND JOHN HPresident and COODec 15Sale187.6713,5902,550,44373,505Dec 17 05:27 PM
RING TIMOTHY MChairman and CEODec 15Sale187.679,1431,715,828101,694Dec 17 05:27 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 14Option Exercise84.585,627475,90429,273Dec 16 12:37 PM
Beasley Jim CGroup PresidentDec 14Option Exercise103.3420,5772,126,52844,890Dec 16 12:37 PM
WEILAND JOHN HPresident and COODec 14Option Exercise97.6933,5693,279,188112,978Dec 16 12:37 PM
WEILAND JOHN HPresident and COODec 14Sale184.2533,5696,185,03073,505Dec 16 12:37 PM
Beasley Jim CGroup PresidentDec 14Sale184.7820,5773,802,14924,313Dec 16 12:37 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 14Sale184.005,6271,035,36823,646Dec 16 12:37 PM
RING TIMOTHY MChairman and CEOOct 29Option Exercise86.3230,5432,636,410150,237Nov 02 01:05 PM
RING TIMOTHY MChairman and CEOOct 29Sale184.7930,5435,644,042119,694Nov 02 01:05 PM
Naughton Gail KDirectorOct 27Option Exercise85.932,000171,8624,014Oct 28 04:02 PM
Naughton Gail KDirectorOct 27Sale181.992,458447,3251,556Oct 28 04:02 PM
RING TIMOTHY MChairman and CEOSep 29Option Exercise85.2340,0003,409,000159,694Oct 01 10:05 AM
RING TIMOTHY MChairman and CEOSep 29Sale185.1640,0007,406,546119,694Oct 01 10:05 AM
RING TIMOTHY MChairman and CEOAug 31Option Exercise85.2340,0003,409,000159,694Sep 02 01:59 PM
RING TIMOTHY MChairman and CEOAug 31Sale195.1740,0007,806,995119,694Sep 02 01:59 PM
Luboff Sharon MGroup Vice PresidentAug 18Option Exercise81.702,374193,94430,773Aug 20 09:12 AM
Luboff Sharon MGroup Vice PresidentAug 18Sale199.762,374474,23428,399Aug 20 09:12 AM
Luboff Sharon MGroup Vice PresidentAug 17Option Exercise81.701,03084,14629,429Aug 17 05:00 PM
Luboff Sharon MGroup Vice PresidentAug 17Sale200.001,030206,00028,399Aug 17 05:00 PM
Thompson Tommy GDirectorAug 14Option Exercise73.991,20088,7889,519Aug 17 05:00 PM
Thompson Tommy GDirectorAug 14Sale199.251,200239,1038,319Aug 17 05:00 PM
Luboff Sharon MGroup Vice PresidentAug 13Option Exercise81.701,00081,69529,399Aug 17 05:00 PM
Luboff Sharon MGroup Vice PresidentAug 13Sale200.001,000200,00028,399Aug 17 05:00 PM
Groetelaars John PGroup PresidentAug 07Option Exercise85.289,416802,98727,063Aug 11 02:00 PM
Groetelaars John PGroup PresidentAug 07Sale196.689,4161,851,98517,647Aug 11 02:00 PM
Christian Patricia GVP -Quality, Reg & Med AffairsAug 05Option Exercise84.581,677141,83214,363Aug 07 02:43 PM
Collins Timothy PGroup PresidentAug 05Option Exercise84.5825,9672,196,15957,479Aug 07 02:43 PM
Collins Timothy PGroup PresidentAug 05Sale199.7625,9675,187,15531,512Aug 07 02:43 PM
Christian Patricia GVP -Quality, Reg & Med AffairsAug 05Sale199.162,093416,84212,270Aug 07 02:43 PM
DeFord John ASr. VP Sci Tech and Clin AfrsAug 04Option Exercise109.6213,4851,478,21237,131Aug 06 12:22 PM
DeFord John ASr. VP Sci Tech and Clin AfrsAug 04Sale197.7513,4852,666,60123,646Aug 06 12:22 PM
Luboff Sharon MGroup Vice PresidentAug 03Option Exercise81.705,000408,47533,399Aug 05 09:17 AM
Luboff Sharon MGroup Vice PresidentAug 03Sale195.995,000979,95928,399Aug 05 09:17 AM
Lupisella Frank JrVice President and ControllerJul 31Sale196.002,685526,26014,740Aug 03 01:23 PM
RING TIMOTHY MChairman and CEOJul 29Option Exercise85.2340,0003,409,000159,710Jul 31 01:52 PM
RING TIMOTHY MChairman and CEOJul 29Sale193.6340,0007,745,099119,710Jul 31 01:52 PM
RING TIMOTHY MChairman and CEOJul 24Option Exercise81.7020,0001,633,900139,710Jul 28 03:29 PM
Beasley Jim CGroup PresidentJul 24Option Exercise136.375,944810,58330,257Jul 28 03:29 PM
RING TIMOTHY MChairman and CEOJul 24Sale186.3120,0003,726,103119,710Jul 28 03:29 PM
Luboff Sharon MGroup Vice PresidentJul 24Sale184.002,891531,94428,399Jul 28 03:29 PM
Lupisella Frank JrVice President and ControllerJul 24Sale190.002,686510,34017,425Jul 28 03:29 PM
Beasley Jim CGroup PresidentJul 24Sale185.005,9441,099,64024,313Jul 28 03:29 PM
RING TIMOTHY MChairman and CEOJul 13Option Exercise88.7620,0001,775,100139,710Jul 14 04:15 PM
RING TIMOTHY MChairman and CEOJul 13Sale176.0420,0003,520,872119,710Jul 14 04:15 PM
Groetelaars John PGroup PresidentJul 13Sale175.002,456429,80017,647Jul 14 04:15 PM
Thompson Tommy GDirectorApr 28Option Exercise63.431,20076,1169,519Apr 29 05:36 PM
Thompson Tommy GDirectorApr 28Sale170.431,200204,5158,319Apr 29 05:36 PM
Naughton Gail KDirectorApr 28Sale170.61763130,1782,008Apr 29 05:36 PM
RING TIMOTHY MChairman and CEOMar 23Option Exercise83.477,628636,732129,083Mar 25 09:38 AM
RING TIMOTHY MChairman and CEOMar 23Sale170.657,6281,301,687121,455Mar 25 09:38 AM
BRESLAWSKY MARC CDirectorFeb 24Option Exercise76.367,200549,76619,319Feb 26 06:13 PM
BRESLAWSKY MARC CDirectorFeb 24Sale174.377,2001,255,49312,119Feb 26 06:13 PM
RING TIMOTHY MChairman and CEOFeb 23Option Exercise83.4720,0001,669,460141,455Feb 25 07:28 PM
RING TIMOTHY MChairman and CEOFeb 23Sale176.3320,0003,526,583121,455Feb 25 07:28 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 20Option Exercise96.5111,4401,104,05837,111Feb 24 07:08 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 20Sale176.0316,0912,832,52321,020Feb 24 07:08 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 20Sale174.852,987522,26423,646Feb 24 07:08 PM
Beasley Jim CGroup PresidentFeb 19Sale174.792,884504,10424,313Feb 20 03:51 PM
Groetelaars John PGroup Vice PresidentFeb 19Sale175.144,566799,70520,103Feb 20 03:51 PM
Luboff Sharon MGroup Vice PresidentFeb 19Sale174.421,117194,83031,149Feb 20 03:51 PM
WEILAND JOHN HPresident and COOFeb 19Sale174.998,4131,472,21179,409Feb 20 03:51 PM
RING TIMOTHY MChairman and CEOFeb 18Sale175.454,531794,980121,455Feb 20 03:51 PM
Collins Timothy PGroup PresidentFeb 18Sale175.554,583804,53831,512Feb 20 03:51 PM
Christian Patricia GVP -Quality, Reg & Med AffairsFeb 18Sale175.561,213212,95612,679Feb 20 03:51 PM
HENKEL HERBERT LDirectorFeb 17Option Exercise76.367,200549,76617,561Feb 19 05:29 PM
WEILAND JOHN HPresident and COOFeb 17Sale174.5113,6162,376,18087,822Feb 18 05:48 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 17Sale174.586,1461,072,95126,633Feb 18 05:48 PM
Beasley Jim CGroup PresidentFeb 17Sale174.589,9041,729,00627,197Feb 18 05:48 PM
Luboff Sharon MGroup Vice PresidentFeb 17Sale174.578,7721,531,29732,266Feb 18 05:48 PM
Collins Timothy PGroup PresidentFeb 17Sale174.572,210385,79540,253Feb 18 05:48 PM
RING TIMOTHY MChairman and CEOFeb 17Sale175.182,453429,721130,097Feb 18 05:48 PM
HENKEL HERBERT LDirectorFeb 17Sale174.607,2001,257,12810,361Feb 19 05:29 PM